| 基于科学—技术—产品关联分析测度新药研发成果转化及其启示 |
| 修订日期：2017-04-06 点此下载全文 |
| 引用本文：杜建,唐小利.基于科学—技术—产品关联分析测度新药研发成果转化及其启示[J].医学信息学杂志,2017,38(6):59-65 |
| 摘要点击次数: |
| 全文下载次数: |
|
| 基金项目:ISTIC-Thomson Reuters科学计量学联合实验室开放基金“基于科学与技术关联分析测度转化研究：方法与实证”（资金项目:IT2014005）；国家科技图书文献中心（NSTL）“面向重大新药创制科技重大专项的专业化信息服务”。 |
|
| 中文摘要:以2006-2015年美国FDA批准上市的新药为基础数据，基于本文提出的转化研究测度回溯模型，测度“新药产品—核心专利—科技论文—基金资助”之间的知识关联，提出促进我国医药产品创新的政策建议。 |
| 中文关键词:转化研究 科学计量学 科技政策 FDA新药橘皮书 非专利文献 |
| |
| The Measurement of New Drug R&D Achievement Transformation Based on the Analysis of the Correlation among Science, Technology and Product as Well as the Enlightenment |
|
|
| Abstract:Based on the translational research measurement and backtracking model put forward in this paper,it takes the new drug approved to enter into the market by American FDA from 2006-2015 as the fundamental data to measure the knowledge relations among "new drug products-core patent-scientific paper-fund assistance", and puts forward the policies and suggestions for promoting innovation of pharmaceutical products in China. |
| keywords:Translational research Scientometric Science policy FDA orange book about new drug Non-patent literature |
| 查看全文 查看/发表评论 下载PDF阅读器 |
